Gossamer Bio (GOSS) EBIT Margin (2022 - 2025)
Historic EBIT Margin for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 369.44%.
- Gossamer Bio's EBIT Margin fell 116500.0% to 369.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 802.08%, marking a year-over-year decrease of 7329400.0%. This contributed to the annual value of 66.06% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's EBIT Margin is 369.44%, which was down 116500.0% from 337.41% recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's EBIT Margin ranged from a high of 1612.12% in Q3 2022 and a low of 372.23% during Q1 2025
- For the 4-year period, Gossamer Bio's EBIT Margin averaged around 593.99%, with its median value being 247.08% (2024).
- Examining YoY changes over the last 5 years, Gossamer Bio's EBIT Margin showed a top increase of -116500bps in 2025 and a maximum decrease of -3917600bps in 2025.
- Quarter analysis of 4 years shows Gossamer Bio's EBIT Margin stood at 1572.37% in 2022, then dropped by -13bps to 1369.77% in 2023, then crashed by -82bps to 247.08% in 2024, then crashed by -250bps to 369.44% in 2025.
- Its EBIT Margin was 369.44% in Q3 2025, compared to 337.41% in Q2 2025 and 372.23% in Q1 2025.